ATE307589T1 - Verabreichung von produkten des 5- lipoxygenasestoffwechsels zur steigerung der antimikrobiellen abwehr - Google Patents
Verabreichung von produkten des 5- lipoxygenasestoffwechsels zur steigerung der antimikrobiellen abwehrInfo
- Publication number
- ATE307589T1 ATE307589T1 AT97954070T AT97954070T ATE307589T1 AT E307589 T1 ATE307589 T1 AT E307589T1 AT 97954070 T AT97954070 T AT 97954070T AT 97954070 T AT97954070 T AT 97954070T AT E307589 T1 ATE307589 T1 AT E307589T1
- Authority
- AT
- Austria
- Prior art keywords
- administration
- products
- metabolism products
- antimicrobial defense
- increase antimicrobial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/757,136 US5909734A (en) | 1996-12-03 | 1996-12-03 | Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense |
| PCT/US1997/022635 WO1998024397A2 (en) | 1996-12-03 | 1997-12-03 | Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE307589T1 true ATE307589T1 (de) | 2005-11-15 |
Family
ID=25046516
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05016311T ATE457730T1 (de) | 1996-12-03 | 1997-12-03 | Verabreichung von produkten des 5-lipoxygenase synthesewegs zur behandlung von mikrobiellen infektionen |
| AT97954070T ATE307589T1 (de) | 1996-12-03 | 1997-12-03 | Verabreichung von produkten des 5- lipoxygenasestoffwechsels zur steigerung der antimikrobiellen abwehr |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05016311T ATE457730T1 (de) | 1996-12-03 | 1997-12-03 | Verabreichung von produkten des 5-lipoxygenase synthesewegs zur behandlung von mikrobiellen infektionen |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US5909734A (de) |
| EP (2) | EP1602375B1 (de) |
| AT (2) | ATE457730T1 (de) |
| AU (1) | AU733567B2 (de) |
| CA (1) | CA2278140C (de) |
| DE (2) | DE69734476T2 (de) |
| DK (1) | DK1037640T3 (de) |
| ES (2) | ES2341255T3 (de) |
| WO (1) | WO1998024397A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7473708B2 (en) | 1996-02-15 | 2009-01-06 | Jean Gosselin | Agents with leukotriene B4-like antiviral (enveloped RNA) activities |
| US5909734A (en) * | 1996-12-03 | 1999-06-08 | Regents Of The University Of Michigan | Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense |
| KR100325581B1 (ko) * | 1998-08-07 | 2002-08-24 | 오우택 | 아라키토닉산의리폭시게네이즈대사결과물질을함유하는진통제용조성물 |
| WO2004112795A1 (en) * | 2003-06-25 | 2004-12-29 | Ltb4 Sweden Ab | Ltb4 compositions for treating tract infections |
| WO2005102309A2 (en) * | 2004-04-26 | 2005-11-03 | Ltb4 Sweden Ab | In vivo release of endogenous anti-microbial mediators by leukotriene b4 (ltb4) administration |
| ATE474603T1 (de) * | 2004-09-20 | 2010-08-15 | Ltb4 Sweden Ab | Stabilisiertes leukotrien b4 (ltb4) pharmazeutikum |
| CN107233337A (zh) | 2009-04-29 | 2017-10-10 | 阿马里纳药物爱尔兰有限公司 | 含有epa和心血管剂的药物组合物以及使用其的方法 |
| CN112546196A (zh) * | 2020-02-29 | 2021-03-26 | 中国人民解放军总医院第三医学中心 | 肌动蛋白聚合诱导剂在制备抵抗或抑制肺炎克雷伯氏菌的药物中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4821714A (en) * | 1986-12-04 | 1989-04-18 | Smelser Danny N | Pharmaceutical endotracheal tube |
| US5314918A (en) * | 1987-06-24 | 1994-05-24 | Smithkline Beecham Corporation | Leukotriene antagonists |
| US5145861A (en) * | 1987-11-04 | 1992-09-08 | Merrell Dow Pharmaceuticals Inc. | Fluorinated arachidonic acid derivatives |
| DK0629213T3 (da) * | 1992-03-07 | 1996-11-18 | Morinaga Milk Industry Co Ltd | Anvendelse af et immunstimulerende middel |
| US5674483A (en) * | 1995-01-31 | 1997-10-07 | National Jewish Medical And Research Center | Treatment for diseases involving inflammation |
| US5789441A (en) * | 1996-02-15 | 1998-08-04 | Virocell Inc. | Leukotriene B4 as an antiviral and anti-neoplastic agent |
| US5909734A (en) * | 1996-12-03 | 1999-06-08 | Regents Of The University Of Michigan | Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense |
-
1996
- 1996-12-03 US US08/757,136 patent/US5909734A/en not_active Expired - Lifetime
-
1997
- 1997-12-03 DK DK97954070T patent/DK1037640T3/da active
- 1997-12-03 DE DE69734476T patent/DE69734476T2/de not_active Expired - Lifetime
- 1997-12-03 EP EP05016311A patent/EP1602375B1/de not_active Expired - Lifetime
- 1997-12-03 CA CA002278140A patent/CA2278140C/en not_active Expired - Fee Related
- 1997-12-03 AT AT05016311T patent/ATE457730T1/de not_active IP Right Cessation
- 1997-12-03 ES ES05016311T patent/ES2341255T3/es not_active Expired - Lifetime
- 1997-12-03 DE DE69739775T patent/DE69739775D1/de not_active Expired - Lifetime
- 1997-12-03 ES ES97954070T patent/ES2251748T3/es not_active Expired - Lifetime
- 1997-12-03 WO PCT/US1997/022635 patent/WO1998024397A2/en not_active Ceased
- 1997-12-03 AT AT97954070T patent/ATE307589T1/de active
- 1997-12-03 AU AU57942/98A patent/AU733567B2/en not_active Ceased
- 1997-12-03 EP EP97954070A patent/EP1037640B1/de not_active Expired - Lifetime
-
1999
- 1999-03-03 US US09/291,656 patent/US7696148B1/en not_active Expired - Fee Related
-
2005
- 2005-01-19 US US11/038,883 patent/US20050267211A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE457730T1 (de) | 2010-03-15 |
| US20050267211A1 (en) | 2005-12-01 |
| WO1998024397A2 (en) | 1998-06-11 |
| US5909734A (en) | 1999-06-08 |
| US7696148B1 (en) | 2010-04-13 |
| ES2341255T3 (es) | 2010-06-17 |
| EP1602375A3 (de) | 2005-12-14 |
| WO1998024397A3 (en) | 1998-09-03 |
| CA2278140A1 (en) | 1998-06-11 |
| EP1037640B1 (de) | 2005-10-26 |
| EP1602375B1 (de) | 2010-02-17 |
| CA2278140C (en) | 2008-02-05 |
| DE69734476D1 (de) | 2005-12-01 |
| AU733567B2 (en) | 2001-05-17 |
| DE69739775D1 (de) | 2010-04-01 |
| EP1037640A2 (de) | 2000-09-27 |
| EP1602375A2 (de) | 2005-12-07 |
| DK1037640T3 (da) | 2006-03-13 |
| EP1037640A4 (de) | 2003-07-23 |
| AU5794298A (en) | 1998-06-29 |
| ES2251748T3 (es) | 2006-05-01 |
| DE69734476T2 (de) | 2006-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU8335291A (en) | Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals | |
| NZ514260A (en) | A composition comprising Group C streptococcal phage associated lysin enzyme, and the use of this composition for preventing or treating streptoccocal infections | |
| ATE207755T1 (de) | Pharmazeutische zusammensetzungen enthaltend lactobacillus brevis und lactobacillus salivarius zur behandlung von vaginainfektionen | |
| IL106842A (en) | Pharmaceutical compositions comprising il-4r or derivatives thereof for the treatment, prophylaxis and diagnosis of allergic, viral, parasitic and bacterial diseases and fungal infections | |
| NO991548L (no) | Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer | |
| EP1037640A4 (de) | Verabreichung von produkten des 5-lipoxygenasestoffwechsels zur steigerung der antimikrobiellen abwehr | |
| AU1794601A (en) | Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs | |
| EE03597B1 (et) | Farmatseutiline kompositsioon, mis sisaldab Lactobacillus plantarum'it ja arginiini | |
| EP1013282A3 (de) | Arznei- und Nahrungsmittel enthaltend Transferrine und antibakterielle Wirkstoffe zur Förderung der Immunabwehr und zur Behandlung von Infektionen | |
| DE69914911D1 (de) | Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen | |
| KR950026524A (ko) | 피부질환 치료용 의약조성물 | |
| DE69419782D1 (de) | Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung | |
| DE69929616D1 (de) | Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen | |
| ATE121459T1 (de) | Antibiotika ge 2270 faktoren b1, b2, c1, d1, d2, e und t. | |
| JPS6483025A (en) | Blended preparation of drug-resistant live bacterium agent for controlling intestinal function and antibacterial agent | |
| ATE413170T1 (de) | Medizinische zusammensetzung zur behandlung von infektionen mit arzneimittelresistentem staphylococcus aureus | |
| BR0318497A (pt) | composto de droga antibacteriana compreendendo n-acetil-d-glucosamina | |
| RU2003347C1 (ru) | Средство дл лечени протейной инфекции | |
| RU94024111A (ru) | Способ профилактики кишечных инфекций | |
| HK40087462A (en) | New recombinant lysin and its use in the treatment of gram-negative bacterial infections | |
| LEE et al. | A Case of Sepsis due to Vibrio damsela | |
| Kitahara | Methods of enhancing the treatment of infections- Secrets to the selection and use of antibiotics | |
| RU94024117A (ru) | Способ лечения гастроэнтероколита | |
| Sgromo et al. | Hyperbaric oxygen therapy in anaerobic infection(sepsis) in children. | |
| Ratliff et al. | Replantation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1037640 Country of ref document: EP |